Examples of Our Services

Negotiating and drafting non-commercial and investigator-led clinical trial agreements for a well-known cancer research charity. This included providing general contract advice and drafting in relation to laboratory agreements and research collaborations for Phase II, III and IV clinical trials.

Contact us

Providing advice in relation to medical device commercial feasibility studies for an international pharmaceutical company, including associated drafting and negotiation input for R&D Agreements, reimbursement agreements, NDAs and material transfer agreements.

Contact us

Drafting and negotiating product development agreements and licence arrangements for generic products.

Contact us

Advising a cell therapy University spin-out on a venture capital and angel (SEIS/EIS) investment deal, EMI and other share option schemes, employment contracts, consultancy agreements and research collaboration agreements.

Contact us

Drafting and negotiating the development and commercialisation collaboration of a new product, combining a novel delivery system and an existing medicine.

Contact us

Advising a UK pharmaceutical company in the negotiation and drafting of a suite of agreements with an Indian generic company, including a manufacture & supply agreement and a dossier licence.

Contact us

Advising a UK pharmaceutical company in the drafting and negotiation of various international pharmaceutical distribution agreements, both as supplier and distributor.

Contact us

Advising brand owners and traders in the parallel trade of pharmaceuticals and medical devices, both strategically and in disputes. This work covers the repackaging of products (including the BMS trade mark conditions), the Specific Mechanism and the general international exhaustion of IP rights. We have recently acted for a trader in legal proceedings concerning the parallel importation of a range of medical devices from continental Europe into the UK. In another example, we have advised a large multinational company on parallel trade strategy, disputes with brand owners and two threatened judicial proceedings against the MHRA.

Contact us

Advising and representing a client where its product came under scrutiny over alleged shortcomings in its pharmacovigilance practices, with related liability and corporate reputation considerations.

Contact us

Advising and working closely with a big pharma company on ABPI Code issues around promotional information, and advising a smaller company on the merits of making complaints against a competitor.

Contact us

Representing a client in its appeal against a negative recommendation by NICE on its cancer product.

Contact us

Advising a client on establishing international policies and standard operating procedures to demonstrate appropriate risk management disciplines and compliance with various HCP ‘sunshine law’ requirements.

Contact us

Advising on an array of intellectual property issues, including the global trade mark protection needed to bolster the value in the brand, ensuring the transfers of intellectual property portfolios and marketing authorisations, and providing advice to a well-known pharma company regarding various patent issues.

Contact us

Advising on patient consents in clinical trials. Assisting a leading global contract development and drug manufacturing organisation with providing IT and Data Protection policies to its employees. In addition, helping a pharma supplier with its privacy policies with healthcare professionals, and advising on international transfers of data.

Contact us

Advising and drafting documentation for a variety of corporate M&A transactions, including the acquisition of several high street healthcare products (baby and oral hygiene) for a leading over-the-counter pharmaceutical company. Our solicitors have also advised on the disposal of a pharmaceuticals business that involved complex issues across four time zones and the sale of a large shareholding in a UK and Indian pharmaceutical company dealing with nicotine replacement products.

Contact us

Drafting and advising on an investment agreement regarding a £20 million investment in a pharmaceutical company by way of a subscription and loan. Also advising numerous life sciences University spin-outs, startups and scaleups on seed and Series A angel and venture capital investment deals (including SEIS and EIS investment deals), including advising companies in cell & gene therapy and vaccine technology.

Contact us

Advising Universities and spin-outs alike on the process of spinning out from the University, including the negotiation of subscription and shareholder agreements, articles of association, collaboration agreements (including those based on the Lambert templates) and appropriate licences of patents, know-how and other IP and other ancillary documents.

Contact us

Negotiating and drafting an agreement for provision by a developer of an app for measuring delivery of medicines.

Contact us

Advising UK and overseas companies in the negotiation and drafting of various kinds of cross-border contracts. This included development, distribution, manufacture & supply, and dossier licence agreements. A recent example was acting for a UK pharmaceutical company in the drafting and negotiation of a suite of agreements with an Indian generic company. The agreements included a manufacture & supply agreement and a dossier licence. We also developed a suite of documentation for a specialist OTC pharmaceutical company for dealings with secondary healthcare markets including agency and distribution arrangements, warehousing and manufacturing agreements.

Contact us

Helping clients needing to secure and retain talent including with advice on settled status.

Contact us

Assisting a generics company with various employment challenges and negotiating the settlement of employment disputes between pharmaceutical companies and employees, including attending the Employment Tribunal.

Contact us

Helping a pharmaceutical wholesaler move to new fit-for-purpose premises.

Contact us

We have provided pharma companies with short-term secondment support to help by acting as a stop-gap for urgent needs to boost their internal legal teams.

Contact us